ReviewTherapeutic advances in musculoskeletal disease2025
RAGing ahead in rheumatology: new language model architectures to tame artificial intelligence.
Review in Therapeutic advances in musculoskeletal disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- A Locally Executable AI System for Improving Preoperative Patient Communication: Multidomain Clinical Evaluation.JMIR medical informatics · 2026Article
- Post-stroke rehabilitation in inflammatory rheumatic diseases: outcome measures, digital tools, and patient education perspectives.Rheumatology international · 2026Review
- Artificial intelligence in rheumatology and paediatric rheumatology: insights from an international survey by EMEUNET.EULAR rheumatology open · 2026Article
- Global perspectives on rheumatology training: insights from the EULAR 2025 EMEUNET Presents session.EULAR rheumatology open · 2026Review
- Natural language processing to intercept rheumatoid and psoriatic arthritis from clinical notes in the Emergency Department.Therapeutic advances in musculoskeletal disease · 2026Article
- Optimising the clinical application of rheumatology guidelines using large language models: a retrieval-augmented generation framework integrating EULAR and ACR recommendations.EULAR rheumatology open · 2025Article
- Advancing artificial intelligence in rheumatology from evidence to practice.Therapeutic advances in musculoskeletal disease · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial intelligence (AI) is increasingly transforming rheumatology with research on disease detection, monitoring, and outcome prediction through the analysis of large datasets. The advent of generative models and large language models (LLMs) has expanded AI's capabilities, particularly in natural language processing (NLP) tasks such as question-answering and medical literature synthesis. While NLP has shown promise in identifying rheumatic diseases from electronic health records with high accuracy, LLMs face significant challenges, including hallucinations and a lack of domain-specific knowledge, which limit their reliability in specialized medical fields like rheumatology. Retrieval-augmented generation (RAG) emerges as a solution to these limitations by integrating LLMs with real-time access to external, domain-specific databases. RAG enhances the accuracy and relevance of AI-generated responses by retrieving pertinent information during the generation process, reducing hallucinations, and improving the trustworthiness of AI applications. This architecture allows for precise, context-aware outputs and can handle unstructured data effectively. Despite its success in other industries, the application of RAG in medicine, and specifically in rheumatology, remains underexplored. Potential applications in rheumatology include retrieving up-to-date clinical guidelines, summarizing complex patient histories from unstructured data, aiding in patient identification for clinical trials, enhancing pharmacovigilance efforts, and supporting personalized patient education. RAG also offers advantages in data privacy by enabling local data handling and reducing reliance on large, general-purpose models. Future directions involve integrating RAG with fine-tuned, smaller LLMs and exploring multimodal models that can process diverse data types. Challenges such as infrastructure costs, data privacy concerns, and the need for specialized evaluation metrics must be addressed. Nevertheless, RAG presents a promising opportunity to improve AI applications in rheumatology, offering a more precise, accountable, and sustainable approach to integrating advanced language models into clinical practice and research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.